calanolide derivatives (Hughes Institute)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namecalanolide derivatives (Hughes Institute)
Drug Alias NameBTK inhibitor (Hughes)Bruton's tyrosine kinase inhibitor (Hughes)HI-D12WHI-P63WHI-D12 +[7] 
ClassificationSmall molecules
Mechanisms of ActionTyrosine-protein kinase BTK inhibitorsAnticancer protein kinase inhibitors
TargetsTyrosine-protein kinase BTK
Therapy Area/IndicationsLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHughes Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHughes Institute
Active IndicationsN/A
Inactive IndicationsLeukemia

Other Information

ATC CodeN/A
Related LinksN/A